Prognostic impact of PSMA PET-CT and conventional imaging staging for cN0M0 intermediate/high-risk localized prostate cancer undergoing extraperitoneal laparoscopic radical prostatectomy with or without standard pelvic lymph node dissection
This study demonstrates that for cN0M0 intermediate-to-high-risk prostate cancer patients undergoing radical prostatectomy, PSMA PET-CT staging provides superior nodal detection compared to conventional imaging, potentially allowing the omission of standard pelvic lymph node dissection without compromising oncological outcomes, whereas such omission remains risky when relying on conventional imaging.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Prostate cancer is a common disease among men, and for those whose cancer is still contained within the prostate gland but carries a moderate to high risk of spreading, surgery to remove the organ is often the best path forward. However, a critical question has long haunted surgeons: does the cancer hide in the nearby lymph nodes, even when standard scans cannot see it? If the cancer has spread to these nodes, simply removing the prostate might not be enough. Traditionally, doctors have relied on a combination of bone scans, CT scans, and MRI images to look for signs of spread. If these conventional images looked clear, surgeons would often still remove a specific set of lymph nodes during the operation just to be safe, a procedure that adds time to the surgery and carries risks of its own. In recent years, a newer, more sensitive imaging tool has emerged, using a special radioactive tracer that latches onto a protein found on prostate cancer cells. This tool can spot tiny clusters of cancer that older scanners miss, offering a clearer picture of where the disease truly is. The big question for doctors was whether this new, sharper view could change the rules of surgery, allowing them to skip the lymph node removal in patients who were previously thought to need it.
A team of researchers at Peking University Cancer Hospital and Lhasa People's Hospital set out to answer this question by looking back at the records of nearly 370 men who underwent a specific type of minimally invasive prostate surgery. These men all had prostate cancer that appeared to be confined to the area before their operations, but they were at an intermediate or high risk of the disease being more advanced than it seemed. The researchers split these patients into two groups based on how they were scanned before surgery. One group was staged using the traditional mix of bone scans and CT or MRI images, while the other group was staged using the newer, more sensitive scan that tracks the prostate-specific membrane antigen. Within each of these groups, some men also had a standard removal of their pelvic lymph nodes during surgery, while others did not. The goal was to see if the type of scan used before surgery changed the long-term outcomes, specifically whether the cancer returned in the blood or spread to other parts of the body.
The results revealed a clear difference in what the two imaging methods could see. When the surgeons examined the lymph nodes that were removed, they found that the traditional imaging method missed hidden cancer in about 11 percent of the cases where nodes were taken out. In contrast, the newer scan was much more accurate, missing hidden cancer in only about 5 percent of cases. This suggests that the traditional method often gives a false sense of security, labeling a patient as having no spread when the cancer is actually there. The researchers found that for patients who had the newer scan and were told they had no spread, the rate of finding hidden cancer was very low. This high level of accuracy in ruling out spread is a crucial finding because it suggests that for men with a clean bill of health on this new scan, the extra surgery to remove lymph nodes might not be necessary.
When the researchers looked at the long-term health of the patients, the story became even more nuanced. For the men who had their lymph nodes removed, the type of scan used before surgery did not make a significant difference in how long they went without the cancer returning to their blood or spreading to distant organs. However, the situation changed for the men who did not have their lymph nodes removed. In this group, those who had been staged with the newer, more sensitive scan had a significantly lower risk of their cancer spreading to distant parts of the body compared to those staged with traditional imaging. While the risk of the cancer returning in the blood was similar across the board, the newer scan appeared to identify a group of patients who were truly safe from distant spread, even without the extra lymph node surgery.
The study concludes that the newer imaging tool is superior for checking if cancer has spread to the lymph nodes before surgery. For patients who are staged with this new scan and show no signs of spread, the researchers suggest that it is reasonable to skip the standard removal of pelvic lymph nodes, sparing them the additional risks of that procedure. On the other hand, for patients who are staged using only traditional imaging, the removal of lymph nodes remains a necessary step to ensure any hidden cancer is found and treated. The authors note that while these findings are promising, they come from a single hospital and a retrospective review of past cases, meaning the results need to be confirmed by longer-term studies and randomized trials. Until then, the choice of imaging and surgery should be guided by the specific tools available and the individual risk profile of each patient, with the understanding that the new scan offers a clearer window into the true extent of the disease.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.